Results for tag: "Heavy Menstrual Bleeding Market"

The Heavy Menstrual Bleeding Market is a segment of the Sexual and Reproductive Health Drugs market. It is composed of drugs and treatments used to reduce the amount of menstrual bleeding and associated symptoms. These treatments can include hormonal therapies, non-hormonal therapies, and surgical interventions. Hormonal therapies are used to reduce the amount of bleeding and regulate the menstrual cycle. Non-hormonal therapies are used to reduce the amount of bleeding and can include medications, dietary changes, and lifestyle modifications. Surgical interventions are used to reduce the amount of bleeding and can include endometrial ablation, hysterectomy, and uterine artery embolization. Some companies in the Heavy Menstrual Bleeding Market include Bayer AG, Merck & Co., Inc., Pfizer Inc., Allergan plc, and Teva Pharmaceutical Industries Ltd. Show Less Read more